To ask the Secretary of State for Health and Social Care, with reference to the submission by NHS England to NICE of Form ID6262: Nirmatrelvir plus ritonavir for treating COVID-19 (Partial Rapid Review of TA878), what assessment she has made of the potent
The Department recognises that implementation of the updated National Institute for Health and Care Excellence (NICE) recommendations on nirmatrelvir plus ritonavir (Paxlovid) within the standard three-month timescale that applies to NICE’s recommendation...
Nirmatrelvir/ritonavir